According to The Fly, multiple analysts commented on Moderna’s Phase 3 melanoma-vaccine data, with Bernstein describing the ...
India Education Diary on MSN
BioNTech mRNA manufacturing facility opens
India, Oct. 26 -- The Hon. Colin Brooks MP, Treasurer, State of Victoria, joined Minister for Economic Development Anthony Carbines to open the new BioNTech manufacturing facility in Bundoora on 20 ...
BioNTech recieved a 95 million euro ($110 million) boost from two EU groups that will go toward expanding production of mRNA vaccines in Africa using its modular BioNTainers. (BioNTech) As BioNTech ...
COVID-19 experience raises questions about manufacturing, biological persistence and long-term safety OCALA, Fla., Oct. 26, ...
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative ...
How delivery plays a new role as the key to success in mRNA application across therapeutic approaches For much of the past ...
New center integrates synthetic DNA, mRNA, targeted delivery, and GMP drug product capabilities to help innovators advance genetic medicines from early development through commercial supply Artis ...
Merck and Moderna announced on August 19 that their personalized mRNA cancer vaccine, intismeran autogene, did something cancer immunologists have been waiting nearly a decade to see: it beat ...
Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the onshoring of drug product manufacturing to its Moderna Technology Center in ...
A Journal of Translational Medicine review outlines how mRNA-encoded antibodies, bispecific constructs, and transient CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results